Peptide Half-Life

Definition

Peptide half-life refers to the time required for the concentration of a peptide in the body to decrease by 50%. It is a fundamental pharmacokinetic parameter that determines dosing frequency, duration of action, and overall therapeutic utility in both research and clinical settings.

Why Half-Life Varies Between Peptides

Natural peptides are typically degraded rapidly by proteases in the blood, liver, and kidneys, often giving half-lives measured in minutes. For example, native GnRH has a half-life of approximately 2–4 minutes, while unmodified GLP-1 is cleared within 1–2 minutes by dipeptidyl peptidase-4 (DPP-4).

Structural modifications can dramatically extend half-life. Common strategies include PEGylation, fatty acid acylation (as in semaglutide and liraglutide), D-amino acid substitution, cyclisation, and fusion to albumin or Fc domains. These modifications reduce enzymatic degradation and renal clearance.

Half-Life and Research Design

A peptide’s half-life directly affects experimental protocols. Short-acting peptides like GHRP-6 require frequent dosing or continuous infusion, while long-acting compounds like CJC-1295 DAC can maintain elevated levels for days. Understanding half-life is essential for interpreting pharmacokinetic data and designing dosing regimens in preclinical studies.

Related Peptides

Peptide profiles that reference “Peptide Half-Life” in their research content.